ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

In Brief: Nobel Laurate Joshua Lederberg to Replace Schmidt As President’s Cancer Panel Chairman

June 1, 1979

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011